Article
Smoking metabolic signature modifies the risk of colorectal cancer and interacts with genetic susceptibility: a large-scale prospective cohort study.
BMC cancer - 8 May 2026
Wang Jing, Zhang Jiawei, Wu Zhuoyi, Zhao Yuqiang, Meng Shiyin, Xuan Wenjie, Ni Jing
Abstract excerpt
BACKGROUND: Smoking tobacco is proven to be associated with higher colorectal cancer (CRC) risk. However, the metabolic pathways of smoking and how they relate to CRC risk are unclear. METHODS: A total of 227,898 participants from the UK Biobank were included. A two-stage strategy with a combination of linear regression and Mendelian randomization analysis was employed to identify smoking-related metabolites....
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
